These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7667326)

  • 1. Catalepsy, Fos protein, and dopamine receptor occupancy after long-term haloperidol treatment.
    Coppens HJ; Sebens JB; Korf J
    Pharmacol Biochem Behav; 1995; 51(2-3):175-82. PubMed ID: 7667326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of cataleptic responses to dopamine receptor antagonists after withdrawal from chronic cocaine or cocaine plus dopamine antagonist administration.
    Ushijima I; Mizuki Y; Suetsugi M; Akimoto T; Yamada M
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 May; 22(4):709-21. PubMed ID: 9682282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 dopamine antisense RNA expression vector, unlike haloperidol, produces long-term inhibition of D2 dopamine-mediated behaviors without causing Up-regulation of D2 dopamine receptors.
    Davidkova G; Zhou LW; Morabito M; Zhang SP; Weiss B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1187-96. PubMed ID: 9618422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
    Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
    Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents.
    Gentzel RC; Toolan D; Roberts R; Koser AJ; Kandebo M; Hershey J; Renger JJ; Uslaner J; Smith SM
    Neuropharmacology; 2015 Dec; 99():256-63. PubMed ID: 26044638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced striatal dopamine D(2) receptor-induced [35S]GTPgammaS binding after haloperidol treatment.
    Geurts M; Hermans E; Maloteaux JM
    Eur J Pharmacol; 1999 Oct; 382(2):119-27. PubMed ID: 10528146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models.
    Natesan S; Reckless GE; Nobrega JN; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2006 Sep; 31(9):1854-63. PubMed ID: 16319908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms for metoclopramide-mediated sensitization and haloperidol-induced catalepsy in rats.
    Agovic MS; Yablonsky-Alter E; Lidsky TI; Banerjee SP
    Eur J Pharmacol; 2008 Jun; 587(1-3):181-6. PubMed ID: 18457824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats.
    Lau YS; Petroske E; Meredith GE; Wang JQ
    Neuropharmacology; 2003 Dec; 45(7):986-94. PubMed ID: 14573391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors.
    Merchant KM; Figur LM; Evans DL
    Cereb Cortex; 1996; 6(4):561-70. PubMed ID: 8670682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pertussis toxin on behavioral responses during different withdrawal periods from chronic cocaine treatment.
    Ushijima I; Mizuki Y; Kobayashi T; Aoki T; Suetsugi M; Usami K; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Nov; 24(8):1369-77. PubMed ID: 11125860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of l-stepholidine on forebrain Fos expression: comparison with clozapine and haloperidol.
    Mo YQ; Jin XL; Chen YT; Jin GZ; Shi WX
    Neuropsychopharmacology; 2005 Feb; 30(2):261-7. PubMed ID: 15578005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
    Lee J; Rushlow WJ; Rajakumar N
    Neuroscience; 2007 Nov; 149(3):602-16. PubMed ID: 17913375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of cataleptic responses induced by dopamine receptor antagonists after chronic cocaine administration in mice.
    Ushijima I; Mizuki Y; Yamada M
    Eur J Pharmacol; 1995 Oct; 285(1):55-9. PubMed ID: 8846811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining dopamine D3 receptor occupancy by antipsychotic drugs via [3H]7-OH-DPAT ex vivo autoradiography and its cross-validation via c-fos immunohistochemistry in the rat brain.
    Davoodi N; te Riele P; Langlois X
    Eur J Pharmacol; 2014 Oct; 740():669-75. PubMed ID: 24967534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of drug-induced catalepsy based on dopamine D1, D2, and muscarinic acetylcholine receptor occupancies.
    Haraguchi K; Ito K; Kotaki H; Sawada Y; Iga T
    Drug Metab Dispos; 1997 Jun; 25(6):675-84. PubMed ID: 9193868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. K-channel blockers attenuate the presynaptic effects of the D2/D3 agonist quinpirole in monkeys.
    Rosenzweig-Lipson S; Barrett JE
    Pharmacol Biochem Behav; 1995 Aug; 51(4):843-8. PubMed ID: 7675867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of dopamine supersensitivity in rats after chronic administration of blonanserin: Comparison with haloperidol.
    Hashimoto T; Baba S; Ikeda H; Oda Y; Hashimoto K; Shimizu I
    Eur J Pharmacol; 2018 Jul; 830():26-32. PubMed ID: 29684390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.